Rigel Pharmaceuticals | RIGL - Ebitda





Ebitda 更改 日
Agenus USD -10.11M 19.02M 2025-03
Amgen USD 5.14B 775M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Celldex Therapeutics USD -83.58M 2.76M 2026-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 12.14B 4.26B 2025-12
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Heron Therapeutics USD -3.88M 5.63M 2024-09
Intrexon USD -24.7M 2.92M 2024-06
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 66.78M 83.54M 2025-12
MacroGenics USD 21.95M 55.39M 2025-09
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Rigel Pharmaceuticals USD -4.17M 798K 2023-09
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Veracyte USD 42.8M 488K 2026-03